Subject Area
Anaesthesia and Surgical Intensive Care
Article Type
Original Study
Abstract
Background : Lowering the intraocular pressure (IOP) is regarded as a primary and initial treatment option for glaucoma. Dexmedetomidine and Magnesium sulfate are known to have intraocular pressure-lowering effects which improve visual fields in patients with primary open angle glaucoma and attenuate intraocular pressure spikes induced by tracheal intubation. Aim: To evaluate and compare the safety and efficacy of using Dexmedetomidine versus Magnesium Sulfate on intraocular pressure and the incidence of postoperative hyphema. Methods : This study included 100 patients both male and female with American Society of Anesthesiologists (ASA) physical status class ɪ and ɪɪ scheduled to undergo elective glaucoma surgery. Ten patients were excluded from the study. Included patients were divided into three groups: group (D) included patients who received only Dexmedetomidine, group (M) included patients who received only Magnesium Sulfate and group (C) included patients who received only normal saline 0.9%. Intraocular pressure was recorded on arrival at preanesthetic room and at the end of drug infusion by Schiøtz tonometer. Results : The highest improvement in IOP was detected among group D followed by group M (40.7% versus 38.5%, respectively) and the least in group C with p=0.001. Conclusion : Both Dexmedetomidine and Magnesium Sulfate have intraocular pressure-lowering effects in glaucoma surgery with more reduction using Dexmedetomidine. Lowest incidence of hyphema was recorded with Magnesium Sulfate followed by Dexmedetomidine.
Recommended Citation
Elhadidi, Nourhan E.; Abdelghaffar, Nevert A.; Mageed, Nabil A.; and Tarbay, Amany
(2025)
"Effect Of Dexmedetomidine Versus Magnesium Sulfate On Intraocular Pressure In Glaucoma Surgery: A Randomized Controlled Trial,"
Mansoura Medical Journal: Vol. 55
:
Iss.
3
, Article 7.
Available at:
https://doi.org/10.58775/2735-3990.1501
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.


